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We report herein the case of a 57-year-old lady who had two concomittant lesions, an inflammatory myofibroblastic tumor in the
trachea, and severe granulomatous lesions in the adjacent hilar lymph nodes. While these two lesions shared histological and some
immunohistochemical features lesions. They diﬀered in terms of ALK-1 expression, which was positive in the tracheal tumor and
negative in the lymph nodes. The discussion of the case circles around putative pathophysiological links between the lesions. The
authors favor the idea that the lymph nodes present a sarcoid-like granulomatous reaction to the inflammatory myofibroblastic
tumor in the trachea over a coexistence of two independent entities. However, no conclusive evidence for this interpretation can
be presented based on the existing literature.
1. Case Report
We describe the case of a 57-year-old lady who presented
with hemoptysis. While being initially treated for several
weeks for presumed oesophagitis, hemoptysis continued,
now associated with slight dyspnea, and the patient com-
plained of a new onset of headaches that radiated into the
neck. Bronchoscopy revealed a 1.3 cm endotrachel tumor,
located 6 cm above the bifurcation. Histological examination
of the superficial endoscopic biopsy suggested an inflamma-
tory myofibroblastic tumor (IMT), but the diagnosis was
limited by the paucity of the material. Endoscopic laser
resection was incomplete, but relieved the symptoms for a
while. A CT scan furthermore provided evidence for bilateral
lymphadenopathy and hence sarcoidosis was considered as a
putative diﬀerential diagnosis. About one month after laser
resection, the patient was referred to the thoracic surgery
center of the Lausanne University, medical center, where the
lesion was entirely resected transthoracically with a 2.1 ×
2.2 cm tracheal fragment (Figure 1(a)). Due to its localization
in the immediate vicinity of the carina and the intense fibrous
reaction to preceding laser treatment, a pedicled latissimus
dorsi flap, reinforced with a segment of the 4th rib, was used
for reconstruction [1]. In addition, 15 hilar lymph nodes
were exercised, some of which measuring up to 1.7 cm in
largest dimension. The lady fares well 24 months after the
surgery, with no evidence of tumor recurrence or systemic
dissemination.
Histological Examination of the Tracheal Lesion showed a
dense proliferation of spindle cells, partly with an epithelioid
aspect, arranged in well-organized fascicles (Figure 1(b)). We
appreciated a very mild degree of nuclar atypia, with slightly
irregular nuclear contours and small inconspicuous nucleoli.
The proliferative activity was low (less than 2 mitoses per
10HPF), confirmed by MIB-1 immunohistochemistry. No
atypical mitotic figure was seen. Admixed to the scant stroma
were many inflammatory cells, mostly lymphocytes, plasma
cells, and rare eosinophils and mast cells. The lesion had a
total thickness of 0.5 cm, traversing the tracheal mucosa, but
without invasion into the adjacent cartilage (Figure 1(a)).
By immunohistochemistry, the tumor cells showed a cyto-
plasmic decoration with antibodies to CD68 (both KP-1 and
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Figure 1: Representative image of the inflammatory myofibroblastic tumor (IMT) in the distant tracheal portion in a 57-year-old lady.
(a) Overview of the lesion spanning three cartilage rings (PAS). (b) Note the partly spindly architecture of the lesion, with only very mild
nuclear atypia and absent mitotic activity (H&E). Immunohistochemical documentation of CD68 expression (clone PGM1, (c)) and of
ALK1 expression (d). The lower four panels (e)–(h) depict representative images of one of 15 peritracheal lymph nodes in the vicinity of
the tracheal lesion shown in panel (a). (e) Overview over the deep sections through the lymph node, which shows that the granulomatous
lesions largely replaces the lymph node and focally transgresses its capsule (H&E). (f) Higher power magnification of the marked area in (a).
Note the striking granulomatous reaction replacing large parts of the lymph node, with extensive extracapsular extension into the adjacent
adipose tissue. Immunohistochemical documentation of CD68 expression (clone PGM1, (g)) and absence of ALK1 expression (h). The space
bars represent 0.5 cm in (a), 1mm in (e), and 100 µm in (b)–(d) and (f)–(h).
PGM1, Figure 1(c)), S-100 and of ALK1 (Figure 1(d)). The
cells were negative for smooth muscle actin and desmin,
CD1a, CD117, CD21, CD23, CD45, and pan-cytokeratins
(not shown). The presence of multinucleated giant cells in
the vicinity of the luminal surface of the lesion was ascribed
to the preceding interventions (biopsy, laser resection) and
the presence of fungi or bacterial colonies was excluded by
H&E histology and by special stains (PAS, Grokott, Gram
stains, not shown).
Histological examination of the hilar lymph nodes revealed
a marked granulomatous reaction in every one of 15 sampled
nodes. The granulomas were very well delimited, sometimes
confluent into large masses, with an admixture of multinu-
cleated giant cells, but with no evidence of caseous necrosis
(Figures 1(e) and 1(f)). In most areas, the epithelioid his-
tiocytes exhibited a histomorphological aspect reminiscent
of the spindle cells forming the lesion in the trachea.
Microorganisms were ruled out by standard H&E histology
and using special stains (PAS, Grokott, Gram, not shown). In
at least one large lymph node, the capsule was transgressed
by the granulomatous reaction, extending widely into the
adjacent adipose tissue, focally associated with coagulation
necrosis (Figures 1(e) and 1(f)). By immunohistochemistry,
the epithelioid cells reacted positively with CD68 (PGM1,
Figure 1(g)) and focally with S-100, with an admixture of
mostly CD4 positive (T-), less frequent CD20-positive (B-)
lymphocytes. No reaction was detected with CD1a, nor with
ALK-1 (Figure 1(h)), despite repetition of the reaction in
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parallel with the tracheal lesion, in which ALK-1 positivity
was confirmed (Figure 1(a)).
The dilemma was not so much how to name the two
lesions: the spindle cell proliferation in the trachea was
diagnosed as inflammatory myofibroblastic tumor (IMT,
confirmed by ALK1 positivity and by outside expert con-
sultation by Dr. S. Coﬃn, Vanderbilt University) and the
granulomatous spindly lesions in the adjacent hilar nodes,
which diﬀered from the first lesion by their granulomatous
appearance and the absence of immunoreactivity for ALK1,
were diagnosed as sarcoid-like lesions. The dilemma was
rather how to interpret the biology of these two lesions.
IMTs are rarely metastasizing myofibroblastic neoplasms
of low to intermediate malignant potential and predilection
for the lung and abdominopelvic region in children or
young adults [2, 3]. They tend to recur, in approximately
25% of the cases—in particular in delicate sites such as the
trachea, where surgical resection is diﬃcult and hence often
incomplete—and show persistent local and invasive growth
[2, 4]. The prognosis of IMTs is excellent after complete
excision and some tumors may even undergo spontaneous
regression [2, 3].
Histologically, the diagnosis of IMT is based on: (i)
diﬀuse inflammatory infiltration of a spindle cell prolifer-
ation with predominantly plasma cells ( hence the former
term “plasma cell granuloma”), (ii) mild nuclear atypia
including scattered ganglion-like cells, (iii) low mitotic rate
without atypical mitotic figures, and (iv) ALK positivity by
immunohistochemistry and ALK gene rearrangement.
Our case is somewhat special in that a “classic” IMT was
accompanied by a massive granulomatous reaction in the
hilar lymph nodes. What could be the pathophysiological
link between these two co-existing lesions? In the following,
we oﬀer five possible explanations, listed in the order from
least likely to most likely in the authors’ eyes.
(1) The lymph node lesions could represent metastases
of the tracheal IMT into the hilar nodes. Arguments
against this idea are the reported rarity of IMTmetas-
tases into single, let alone multiple lymph nodes [5]
and the diﬀerent histomophological appearance and
immunostaining pattern (see Figure 1).
(2) The tracheal lesions might not be an IMT, but rather
extension of the sarcoidosis to the trachea, with aber-
rant ALK-1 positivity. However, to our knowledge, no
ALK-1 positivity has ever been reported in cases of
well-documented sarcoidosis.
(3) Co-existence of two entirely independent lesions, an
IMT in the trachea and a sarcoidosis of the hilar
nodes. However, the partly overlapping histomor-
phology of the two lesions and the minuscule statisti-
cal probability of two rather rare lesions coexisting in
the same patient, in the same localization, and at the
same time, might be advanced as arguments against
this option.
(4) An as yet unestablished coexistence between a tra-
cheal IMT and a true sarcidosis, in analogy to
the well-established coincidence of sarcoidosis and
testicular tumors in youngmen [6]. In support of this
idea, we might refer to a case report in the french-
speaking medical literature of a coincidence of an
inflammatory pseudotumor of the orbit in a 13 year
old child with a “suspicion of sarcoidosis” [5].
(5) The tracheal IMT inducing a granulomatous, sar-
coid-like reaction in the lymph nodes, just as occa-
sionally seen in the dependent nodes of malignant
epithelial and hematological tumors [7] as well as
in situations of chronic inflammation [8], including
asthma [9], aspergilloma [10], and breast implants
[11]. These reactive lesions are thought to arise
secondary to the proliferative action of a distinct
cytokine and growth factor profile [12] and the selec-
tive activation of a distinct subset of T-lymphocytes
[13]. Even though IMTs are often accompanied by
a febrile state and elevated inflammatory markers
that may help to imagine such a pathophysiological
link, our patient did not present with any signs of
inflammation, but rather with symptoms related to
mechanical tracheal obstruction and hemorrhage.
Finally, we need to consider the theoretical possibility
that the initial laser resection of the tumor may
have induced a florid granulomatous reaction in
the dependent lymph nodes, even though we found
no evidence of birefringent or other material (i.e.,
carbon) in the aﬀected lymph nodes.
Among these five possible explanations, the authors
assume that the last version is likely closest to the truth,
even though this conclusion remains largely speculative and
open to discussions. In this context, the authors would be
interested to learn whether any of the distinguished readers
of this case report may have made a similar observation and
kindly ask him/her to share this information with us in order
to better understand this interesting pathophysiological
phenomenon.
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